Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32(3):358–66.
Article CAS PubMed Google Scholar
Barchiesi F, Santinelli A, Biscotti T, Greganti G, Giannini D, Manso E. Delay of antifungal therapy influences the outcome of invasive aspergillosis in experimental models of infection. J Antimicrob Chemother. 2016;71(8):2230–3.
Article CAS PubMed Google Scholar
Lackner N, Thome C, Ofner D, Joannidis M, Mayerhofer T, Arora R, Samardzic E, Posch W, Breitkopf R, Lass-Florl C: COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility. J Fungi (Basel) 2022;8(2):93.
Verweij PE, Rijnders BJA, Bruggemann RJM, Azoulay E, Bassetti M, Blot S, Calandra T, Clancy CJ, Cornely OA, Chiller T, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020;46(8):1524–35.
Article CAS PubMed Google Scholar
Lass-Florl C, Samardzic E, Knoll M. Serology anno 2021-fungal infections: from invasive to chronic. Clin Microbiol Infect. 2021;27(9):1230–41.
Yusuf E, Vonk A, van den Akker JPC, Bode L, Sips GJ, Rijnders BJA, de Steenwinkel J, Verkaik NJ, Vogel M, van der Eerden M et al: Frequency of Positive Aspergillus Tests in COVID-19 Patients in Comparison to Other Patients with Pulmonary Infections Admitted to the Intensive Care Unit. J Clin Microbiol 2021;59(3):e02278–20.
Patterson TF. Clinical utility and development of biomarkers in invasive aspergillosis. Trans Am Clin Climatol Assoc. 2011;122:174–83.
Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis. 2006;42(10):1417–27.
Article CAS PubMed Google Scholar
Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Florl C, Lewis RE, Munoz P, Verweij PE, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1–38.
Page ID, Richardson M, Denning DW. Antibody testing in aspergillosis–quo vadis? Med Mycol. 2015;53(5):417–39.
Article CAS PubMed Google Scholar
Yu Q, He J, Xing B, Li X, Qian H, Zhang H, Xu M, Peng H. Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients. BMC Pulm Med. 2020;20(1):89.
Article CAS PubMed Google Scholar
Dobias R, Jaworska P, Tomaskova H, Kanova M, Lyskova P, Vrba Z, Holub C, Svobodova L, Hamal P, Raska M. Diagnostic value of serum galactomannan, (1,3)-beta-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients. Mycoses. 2018;61(8):576–86.
Article CAS PubMed Google Scholar
Schroeder HW Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S41-52.
Page ID, Richardson MD, Denning DW. Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA). J Infect. 2016;72(2):240–9.
Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367–76.
Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, Dimopoulos G, Paiva JA, Misset B, Rello J, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186(1):56–64.
Hamam J, Navellou JC, Bellanger AP, Bretagne S, Winiszewski H, Scherer E, Piton G, Millon L. Collaborative Rg: New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU. Ann Intensive Care. 2021;11(1):41.
Article CAS PubMed Google Scholar
Li H, Rui Y, Zhou W, Liu L, He B, Shi Y, Su X. Role of the Aspergillus-Specific IgG and IgM Test in the Diagnosis and Follow-Up of Chronic Pulmonary Aspergillosis. Front Microbiol. 2019;10:1438.
Casadevall A, Pirofski LA. Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host Microbe. 2012;11(5):447–56.
Article CAS PubMed Google Scholar
Mahmoud YA, Al-Ghamdi AY, Abd El-Zaher EH. A Protective Mechanism in Lungs of Rats Experimentally Infected with Aspergillus fumigatus. Mycobiology. 2011;39(1):40–4.
Article CAS PubMed Google Scholar
Collier DA, Ferreira I, Kotagiri P, Datir RP, Lim EY, Touizer E, Meng B, Abdullahi A, Collaboration C-NBC-, Elmer A et al: Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature 2021, 596(7872):417–422.
Youn YS, Lee KY, Hwang JY, Rhim JW, Kang JH, Lee JS, Kim JC. Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr. 2010;10:48.
Rodland EK, Ueland T, Pedersen TM, Halvorsen B, Muller F, Aukrust P, Froland SS. Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis. Infect Immun. 2010;78(3):1269–75.
Chebbo M, Duez C, Alessi MC, Chanez P, Gras D: Platelets: a potential role in chronic respiratory diseases? Eur Respir Rev 2021;30(161):210062.
Gago S, Denning DW, Bowyer P: Pathophysiological aspects of Aspergillus colonization in disease. Medical mycology 2019, 57(Supplement_2):S219-S227.
Wu Z, Wang L, Tan L, Wu J, Chen Z, Hu M. Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients. Diagn Microbiol Infect Dis. 2021;99(4): 115274.
Zhou W, Li H, Zhang Y, Huang M, He Q, Li P, Zhang F, Shi Y, Su X. Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis. J Clin Microbiol. 2017;55(7):2153–61.
Article CAS PubMed Google Scholar
Kluge S, Strauss R, Kochanek M, Weigand MA, Rohde H, Lahmer T: Aspergillosis: Emerging risk groups in critically ill patients. Med Mycol 2021;60(1):myab064.
Chen SC. Taiwan’s experience in fighting COVID-19. Nat Immunol. 2021;22(4):393–4.
Article CAS PubMed Google Scholar
Dimopoulos G, Almyroudi MP, Myrianthefs P, Rello J. COVID-19-Associated Pulmonary Aspergillosis (CAPA). J Intensive Med. 2021;1(2):71–80.
Page ID, Baxter C, Hennequin C, Richardson MD, van Hoeyveld E, van Toorenenbergen AW, Denning DW. Receiver operating characteristic curve analysis of four Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis. Diagn Microbiol Infect Dis. 2018;91(1):47–51.
Article CAS PubMed Google Scholar
Tirelli C, M DEA, Piloni D, Sacchi L, Mariani F, Testa G, Torre C, Ciprandi G, Centanni S, Marseglia G et al: Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of Invasive Pulmonary Aspergillosis: a prospective cohort study. Minerva Med 2022.
Lu Y, Liu L, Li H, Chen B, Gu Y, Wang L, Feng C, Chen C, Chen Y, Sun W et al: The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis. Clin Microbiol Infect 2023.
Hsiao CW, Yen TH, Wu YC, Chen JP, Chen YY, Huang WN, Chen YH, Chen YM. Comparison of Aspergillus-specific antibody cut-offs for the diagnosis of aspergillosis. Front Microbiol. 2022;13:1060727.
Jiang Z, Chen S, Zhu Q, Xiao Y, Qu J. COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City. J Infect Public Health. 2022;15(2):222–7.
留言 (0)